首页 - 股票 - 研报 - 公司研究 - 正文

ESOP targets stabilize earnings expectation but sentiment overhang remains

来源:招银国际 作者:Joseph Wong 2023-03-31 11:21:00
关注证券之星官方微博:
(以下内容从招银国际《ESOP targets stabilize earnings expectation but sentiment overhang remains》研报附件原文摘录)
贝泰妮(300957)
2023 outlook. Despite a miss in 4Q, we think Botanee is set to recover alongwith China’s reopening, thanks to its OMO distribution network and anunchallenged R&D franchise that differentiates from peers. Our channel checksuggested Winona 2M23 sales grew 20%+ on Tmall/ Taobao and 300%+ onTiktok. For its offline business, we still see huge potential to expand fromcurrently 19% to 26% of total revenue by 2024E, when Botanee onlypenetrates less than 5% of the national drug stores at present. We believe thetrend matches well with Botanee’s premium branding, as shopping experienceand direct customer care is prioritized at physical stores. Separately, weexpect a relatively stable GPM for 2023E, despite a potentially widening onlinepromotion incentive, thanks to a rising contribution from high-end/ new brandssuch as AOXMED/ Winona Baby etc. Promotional and R&D expense, in ourview, will grow in line with peers in the post COVID era and, hopefully, theinflation would be partially offset by a lower administration expense.
Positive takeaway from the restrictive shares incentive plan. Along withthe results announcement, Botanee also reported its ESOP plan for its staff.The plan will grant 1.5% of Botanee’s shares to 298 employees (coveringboard members and key operation managers) if the stacked revenue and netprofits growth is not lower than 28%/ 61.3%/ 100%, respectively, for the year2023/24/25E. We view this positively as the target likely exceeds marketexpectation and provides a clear financial guidance to the market.
Sentiment overhang remains. Subsequent to the product scandal over theDouble 11 campaign last year, the departure of co-founder and the sell-offfrom a pre-IPO investor continues to weigh on share price. While areplacement for the founder was appointed internally, Botanee will have toreestablish its track record to the market, particularly when the low hangingfruit of livestreaming distribution is gone.
Earnings change. To reflect the 4Q results and the ESOP target, we cut our2023/24E revenue by 9% each and this leads to an average 9% cut in netprofits for the periods.
Valuation. Our new TP is based on 48.5x end-23E P/E (from 2.0x PEG) thatrepresents -1sd below its average since IPO. We switch our methodology fromPEG to P/E as we now have a longer listing history to reasonably trackBotanee’s historical valuation. We benchmark our target multiple to -1sdbelow average to reflect the sentiment overhang mentioned above.





相关附件

微信
扫描二维码
关注
证券之星微信
APP下载
相关股票:
好投资评级:
好价格评级:
证券之星估值分析提示贝泰妮盈利能力优秀,未来营收成长性一般。综合基本面各维度看,股价合理。 更多>>
下载证券之星
郑重声明:以上内容与证券之星立场无关。证券之星发布此内容的目的在于传播更多信息,证券之星对其观点、判断保持中立,不保证该内容(包括但不限于文字、数据及图表)全部或者部分内容的准确性、真实性、完整性、有效性、及时性、原创性等。相关内容不对各位读者构成任何投资建议,据此操作,风险自担。股市有风险,投资需谨慎。如对该内容存在异议,或发现违法及不良信息,请发送邮件至jubao@stockstar.com,我们将安排核实处理。如该文标记为算法生成,算法公示请见 网信算备310104345710301240019号。
网站导航 | 公司简介 | 法律声明 | 诚聘英才 | 征稿启事 | 联系我们 | 广告服务 | 举报专区
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-